Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

OBJECTIVE: To examine the proposal that pretreatment low dose desensitisation may reduce the incidence of toxicity of sulphasalazine in the treatment of rheumatoid arthritis (RA). METHODS: A double blind, placebo controlled trial was performed with 422 patients satisfying the American College of Rhe...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Ann Rheum Dis
Principais autores:	McInnes, I B, Porter, D, Murphy, E A, Thomson, E A, Madhok, R, Hunter, J A, Pullar, T, Capell, H A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010172/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8660109/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.5.328
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!